Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative…

Overview of attention for article published in Diabetes Therapy, September 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,262 followers.

Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor https://t.co/aY9B15eOIY

Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor https://t.co/ZHSdAi0cVv

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.